SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

ImmunoCellular Therapeutics, Ltd. (IMUC)

IMUC RSS Feed
Add IMUC Price Alert      Hide Sticky   Hide Intro
Moderator: PyschoNoobStock
Search This Board: 
Last Post: 9/19/2017 11:20:39 AM - Followers: 172 - Board type: Free - Posts Today: 1

 


 

 

ImmunoCellular Therapeutics continues to make significant progress in meeting important goals and positioning the company for success. We believe that our cancer vaccine platform has the potential to be transformative in the treatment of cancer, and to create value for all our stakeholders. Our goal is to build ImmunoCellular into a leading, independent commercial-stage cancer immunotherapy company.





Our dendritic cell (DC) vaccine technology and advanced manufacturing offer several advantages over earlier-generation cellular immunotherapies:

Potency
- Matured DCs secrete IL12, which is critical for stimulating T cell killing of cancer cells.
More than 80% of the final manufactured product consists of matured DCs.

Versatility
- Unlike other cell-based vaccines, our DCs target multiple antigens, thus increasing the likelihood of effective treatment.

Efficiency
- Advanced manufacturing enables production of at least 20 doses of vaccine from a single apheresis (blood collection); thus patients do not need to undergo additional apheresis procedures.

Cost-effectiveness
- Compared to the only approved cell-based immunotherapy, our DC vaccines can be manufactured at a significantly reduced cost.

Convenience
- Ability to freeze and store vaccine for months or years eliminates the need to administer to the patient shortly after manufacture.
- Intradermal administration route reduces the time and inconvenience of intravenous infusion for both patient and physician.


Company Information:

21900 Burbank, 3rd Floor
Woodland Hills, CA 91367

Phone: 818-992-2907

http://www.imuc.com 

-
Management:
  
http://imuc.com/team/

Technologies:   http://imuc.com/technology/

Press Releases:   http://imuc.com/press/

http://finance.yahoo.com/q/h?s=IMUC+Headlines
 

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0000822411&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 -

Transfer Agent:

U.S. Stock Transfer Corp.
Suite 200
Glendale, CA 91204-2991

 Investor Relations:

Gary Nash, CEOcast, Inc.

Tel: (212)732-4300
Email: IR@imuc.com




 

 PIPELINE 







http://www.imuc.com/pipeline/ict-107/ict-107-faq

http://www.imuc.com/pipeline/ict-121

http://www.imuc.com/pipeline/ict-140



 UPDATE 



ImmunoCellular has concluded a phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes: ICT-121, a dendritic cell vaccine targeting CD133; ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer killing T-cells.

Announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM). This agreement with PharmaCell, a leading European contract manufacturing organization focuses on the production of human cell therapy products, and is designed to enable ImmunoCellular to access phase 3 supplies of ICT-107, manufactured with ImmunoCellular's commercial-ready production process. ImmunoCellular intends to initiate a Phase 3 registrational program for ICT-107 in the US and in Europe in 2015
.   


>>> What these CANCER vaccines could be worth
 

 NEW  


Investor Presentation -> http://files.shareholder.com/downloads/AMDA-1HS8HT/61684022x0x652321/5FD13B20-8F93-44CE-994E-D5515E5F30FC/IMI_Corporate_Overview.pdf 



 

 

 

 

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
IMUC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMUC News: ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its Plan of Compliance 09/13/2017 04:05:00 PM
IMUC News: Current Report Filing (8-k) 08/28/2017 04:32:17 PM
IMUC News: ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy 08/23/2017 04:05:00 PM
IMUC News: Current Report Filing (8-k) 08/17/2017 04:33:30 PM
IMUC News: Current Report Filing (8-k) 08/17/2017 04:18:12 PM
PostSubject
#4068  Sticky Note ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its PyschoNoobStock 09/13/17 04:16:58 PM
#4102   I only hope we get ICT-107 purchase PR Craig305 09/18/17 07:31:42 PM
#4101   Last hour volume is great... Looks like HOD declaes 09/18/17 03:47:08 PM
#4100   Anymore predictions... zephyroo 09/18/17 03:03:17 PM
#4099   BOOM! PyschoNoobStock 09/18/17 02:50:39 PM
#4098   There gies the 0,36 wall... declaes 09/18/17 02:49:43 PM
#4097   Getting close Perfectshot23 09/18/17 02:45:49 PM
#4096   Need to break .36 badly.. Huge Ask.. PyschoNoobStock 09/18/17 12:58:04 PM
#4095   Broke 0,35 again... i hope for good now. declaes 09/18/17 12:55:32 PM
#4094   long. aristotelisonassis 09/18/17 10:50:58 AM
#4093   Sjorties gettong burned!! Joecanada13 09/18/17 10:50:21 AM
#4092   Indeed... nice to see. More coming. Hold on. declaes 09/18/17 10:46:34 AM
#4091   BOOM! PyschoNoobStock 09/18/17 10:41:49 AM
#4090   i think it goes below .25. Bigstud is here 09/18/17 03:25:22 AM
#4089   Cup and Handle Formation in the making.. PyschoNoobStock 09/15/17 02:23:47 PM
#4088   I notice they are trying too hard.. LOL.. PyschoNoobStock 09/15/17 02:23:30 PM
#4087   Shorts are trying hard here Joecanada13 09/15/17 02:08:54 PM
#4086   Ya, expensive report.. PyschoNoobStock 09/15/17 12:26:49 PM
#4085   Good action here today. tyguy1505 09/15/17 12:26:21 PM
#4084   I think we break into .35s today Joecanada13 09/15/17 12:08:59 PM
#4083   Nice bid.. PyschoNoobStock 09/15/17 12:07:51 PM
#4082   Thank you! We neeed it! :-) PyschoNoobStock 09/15/17 12:02:05 PM
#4081   Love it! Here we go! Joecanada13 09/15/17 11:33:54 AM
#4080   $3500 for the report. Wow. Wantcash 09/15/17 11:27:07 AM
#4079   BOOM! PyschoNoobStock 09/15/17 11:25:16 AM
#4078   Lol talk about timing! Joecanada13 09/15/17 11:24:17 AM
#4077   Gotta be getting close here Joecanada13 09/15/17 11:19:26 AM
#4076   http://www.marketresearchhub.com/report/global-cell-therapy-market-2017-2021-rep PyschoNoobStock 09/13/17 09:55:48 PM
#4075   Indeed. Rs was not needed is not needed. declaes 09/13/17 05:24:25 PM
#4074   Share price isn't the issue here, so a cjf913913 09/13/17 05:07:28 PM
#4073   Indeed.. And they are not even going R/S? PyschoNoobStock 09/13/17 04:56:53 PM
#4072   Great news this should move the pps up nicely. declaes 09/13/17 04:55:18 PM
#4071   BOOM! PyschoNoobStock 09/13/17 04:27:31 PM
#4070   Nice AH movement shurtha2000 09/13/17 04:24:05 PM
#4069   The Company has been granted until December 23, PyschoNoobStock 09/13/17 04:22:01 PM
#4068   ImmunoCellular Therapeutics Announces NYSE MKT Acceptance of its PyschoNoobStock 09/13/17 04:16:58 PM
#4067   The last couple of days there has been microchips 09/13/17 01:34:59 PM
#4066   40% of the float shorted shurtha2000 09/13/17 11:40:21 AM
#4065   One more time and it will break imo. declaes 09/13/17 11:07:06 AM
#4064   .32 hit! PyschoNoobStock 09/13/17 10:15:04 AM
#4063   Weeee.... I think we good to go! PyschoNoobStock 09/13/17 10:14:47 AM
#4062   Damn.. Hit .32.. PyschoNoobStock 09/13/17 10:07:07 AM
#4061   .32 then .35... looking good for a start today declaes 09/12/17 12:21:56 PM
#4060   Need to break .32 PyschoNoobStock 09/12/17 12:12:33 PM
#4059   Possible reversal and move up. Indicators turned positive. whinny 09/12/17 10:03:21 AM
#4058   Wrong decimal place. imrichbeotch 09/07/17 10:23:09 AM
#4057   It never ceases to amaze me how stupid whinny 09/05/17 02:54:40 PM
#4056   Opend at 0,28$ wow great... Lol declaes 09/05/17 11:48:41 AM
#4055   Closed at .028, thats horrible realtalk1337 09/04/17 01:19:32 PM
#4052   Well well... green again... declaes 08/31/17 02:02:00 PM
#4051   83000 bid at 0,28 now... green close today declaes 08/31/17 01:53:04 PM
PostSubject